Resmetirom and Bariatric Surgery: New Frontiers in Treating Obesity-Related Metabolic Dysfunction-Associated Steatohepatitis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Au K;Au K;Au K; Yang W; Yang W
  • Source:
    Obesity surgery [Obes Surg] 2024 Sep; Vol. 34 (9), pp. 3525-3526. Date of Electronic Publication: 2024 Jul 25.
  • Publication Type:
    Editorial; Letter
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-0428 (Electronic) Linking ISSN: 09608923 NLM ISO Abbreviation: Obes Surg Subsets: MEDLINE
    • Publication Information:
      Publication: 2006- : New York : Springer Science + Business Media
      Original Publication: Oxford, OX, UK : Rapid Communications of Oxford, [1991-
    • Subject Terms:
    • References:
      Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016;118(11):1844–55. https://doi.org/10.1161/circresaha.116.307591 . (PMID: 10.1161/circresaha.116.307591272306454888907)
      Klebanoff MJ, Corey KE, Chhatwal J, et al. Bariatric surgery for nonalcoholic steatohepatitis: a clinical and cost-effectiveness analysis. Hepatology. 2017;65(4):1156–64. https://doi.org/10.1002/hep.28958 . (PMID: 10.1002/hep.2895827880977)
      Verrastro O, Panunzi S, Castagneto-Gissey L, et al. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial. Lancet. 2023;401(10390):1786–97. https://doi.org/10.1016/s0140-6736(23)00634-7 . (PMID: 10.1016/s0140-6736(23)00634-737088093)
      Castagneto-Gissey L, Bornstein SR, Mingrone G. Can liquid biopsies for MASH help increase the penetration of metabolic surgery? A narrative review. Metabolism. 2024;151:155721. https://doi.org/10.1016/j.metabol.2023.155721 . (PMID: 10.1016/j.metabol.2023.15572137923007)
      Ren Y, Yang W, Yang J, Wang C. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30–35 kg/m2. Obes Surg. 2015;25(3):457–63. https://doi.org/10.1007/s11695-014-1411-y . (PMID: 10.1007/s11695-014-1411-y25236397)
      Zeng J, Fan JG, Francque SM. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European Gastroenterol J. 2024;12(2):177–86. https://doi.org/10.1002/ueg2.12525 . (PMID: 10.1002/ueg2.125253819386510954426)
      Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–88. https://doi.org/10.1053/j.gastro.2015.04.014 . (quiz e315-376). (PMID: 10.1053/j.gastro.2015.04.01425917783)
      Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159(4):1290-1301.e1295. https://doi.org/10.1053/j.gastro.2020.06.006 . (PMID: 10.1053/j.gastro.2020.06.00632553765)
      Drai C, Chierici A, Pavone G, et al. Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study. Surg Obes Relat Dis. 2024;20(5):482–9. https://doi.org/10.1016/j.soard.2023.10.015 . (PMID: 10.1016/j.soard.2023.10.01538195314)
      Chew NWS, Ng CH, Muthiah MD, Sanyal AJ. Comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease. Curr Atheroscler Rep. 2022;24(7):515–32. https://doi.org/10.1007/s11883-022-01027-5 . (PMID: 10.1007/s11883-022-01027-535507280)
    • Publication Date:
      Date Created: 20240724 Date Completed: 20240827 Latest Revision: 20241008
    • Publication Date:
      20241009
    • Accession Number:
      10.1007/s11695-024-07430-y
    • Accession Number:
      39048755